Huntington's disease: Mortality and risk factors in an Australian cohort

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Huntington's Disease (HD) is a progressive neurodegenerative disorder with significant mortality.
• Risk factors for mortality in HD have not been extensively studied in Australian populations.
• Understanding mortality predictors is crucial for improving patient care and outcomes in HD.

Purpose of the Study:

• To investigate risk factors associated with mortality in an Australian cohort of Huntington's Disease patients.
• To compare mortality rates in HD patients with the general Australian population.
• To identify potential non-genetic factors influencing survival in Huntington's Disease.

Main Methods:

• Retrospective study of 83 inpatients from a specialist neuropsychiatry service in Melbourne, Australia.
• HD diagnosis confirmed by genetic testing; risk factors included age of onset, CAG repeat length, and neuroimaging.
• Mortality data obtained from the Australian Institute of Health and Welfare National Death Index.

Main Results:

• The cohort had 44 (53%) deceased participants; median age of death was 59 years, with median survival 18.8 years post-onset.
• CAG repeat length was inversely correlated with age of onset and death but not mortality status.
• Standardised mortality ratios indicated a 5.9-fold increased risk of death for HD patients compared to the general population.

Conclusions:

• This is the first study to examine HD mortality risk factors in an Australian cohort.
• Median survival is consistent with international HD studies but significantly lower than the general Australian population.
• Non-genetic factors likely contribute to mortality in Huntington's Disease and require further investigation.